Form 4: Jaguar Health Executive Jonathan S. Wolin Reports Stock Transactions
SEC Form 4 Filing
Jonathan S. Wolin, Chief of Staff, CCO & GC of Jaguar Health, Inc., reported the vesting of restricted stock units into common stock on May 17, 2024.
Summary
- On May 17, 2024, Jonathan S. Wolin, Chief of Staff, CCO & GC of Jaguar Health, Inc., reported a transaction involving restricted stock units.
- The transaction involved the vesting of 871 restricted stock units, which converted into 871 shares of common stock.
- These restricted stock units were initially approved on March 28, 2022, and adjusted to reflect a 75-for-1 reverse stock split that took place on January 23, 2023.
- The restricted stock units vest in three equal annual installments starting May 17, 2023.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of insider transactions, which is a common practice for publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects a change in the holdings of a company executive.
Key Dates
| Date | Description |
|---|---|
| March 28, 2022 | Date the issuer's board of directors originally approved the restricted stock units. |
| January 23, 2023 | Date of the 75-for-1 reverse stock split. |
| May 17, 2023 | Start date of the three equal annual installments for vesting of restricted stock units. |
| May 17, 2024 | Date of the reported transaction where restricted stock units vested. |
| May 21, 2024 | Date of signature of the reporting person. |
Keywords
Jaguar Health, Jonathan S. Wolin, restricted stock units, common stock, Form 4, insider trading, vesting, reverse stock split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.